Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesImatinib in Gastrointestinal Stromal Tumor: Does Treatment Duration Matter
Oncology (Karger), 09/10/09
Adenis A et al. – Whereas 10 years ago no effective systemic therapy was available for gastrointestinal stromal tumors, the introduction of imatinib into clinical practice has dramatically improved the outcome of advanced disease, through favorable impact on disease–free survival for some patients with a localized and resectable tumor.
Related Articles
Improved early event-free survival with imatinib in philadelphia chromosome-positive acute lymphoblastic leukemia: a childrens oncology group study
Journal of Clinical Oncology, 10/09/09
Relevance Score: 95%
Healthcare resource utilization and costs associated with non-adherence to imatinib treatment in chronic myeloid leukemia patients
Current Medical Research and Opinion, 11/17/09
Relevance Score: 91%
Rare incidence of congestive heart failure in gastrointestinal stromal tumor and other sarcoma patients receiving imatinib mesylate
Cancer, 11/06/09
Relevance Score: 88%
Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Final results of the CSTIBES02 trial
Haematologica, 10/07/09
Relevance Score: 87%
Phase II Study of Neoadjuvant Imatinib in Glioblastoma: Evaluation of Clinical and Molecular Effects of the Treatment
Clinical Cancer Research, 10/01/09
Relevance Score: 87%
Today in GI Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Optimal surgery for advanced gastric cancer
Expert Review of Anticancer Therapy, 12/07/09
Long-term activation of the pro-coagulant response after neoadjuvant chemoradiation and major cancer surgery
British Journal of Cancer, 12/07/09
Clinical implications of esophagorespiratory fistulae in patients with esophageal squamous cell carcinoma (SCCA)
Medical Oncology, 12/04/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Impact of anti-angiogenic treatments on metastatic renal cell carcinoma
Expert Review of Anticancer Therapy, 12/07/09
Role and rationale of gene therapy and other novel therapies in the management of NMIBC
Expert Review of Anticancer Therapy, 12/07/09
Organ-sparing strategies in the management of invasive bladder cancer
Expert Review of Anticancer Therapy, 12/07/09
Sponsor
Article Search
Sponsor
Sponsor